Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
116
NCT05338099
Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 18, 2022
Completion: Dec 28, 2022
NCT05333406
Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A
Start: Feb 22, 2022
Completion: Dec 20, 2022
NCT06328725
Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy
Phase: Phase 1/2
Start: Mar 31, 2024
Completion: Nov 30, 2025
NCT06328712
Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A
Start: May 30, 2024
Completion: Oct 31, 2025